The regulatory mess with rapid antibody tests in India:

"Companies need approval from the National Institute of Virology for efficacy of kits and an import licence from drug controller. Many companies have the approval or the licence, not both."

https://m.economictimes.com/industry/healthcare/biotech/with-concerns-over-kit-quality-antibody-testing-yet-to-take-off/amp_articleshow/75090304.cms

. @rdivia and @Teensthack's report seems to answer the question on my mind since April 5 when the drug controller released this list of 29 "approved" kits with a vague addendum "with the conditions to get validated at NIV, Pune"

Thread on long-running mess https://twitter.com/sharmasupriya/status/1246805258812055555